MUB Medical Secures U.S. Patent for Sutrips
MUB Medical is proud to announce that Sutrips has officially been granted a U.S. patent.
This achievement marks a major milestone in our journey and further strengthens our robust global IP portfolio, which already includes patents in Europe, China, Eurasia, Russia, Australia, Mexico, Brazil, Indonesia, India, and South Africa – and now also the United States.
Sutrips is more than just a medical device; it is a versatile acute wound closure platform designed to simplify suturing across a wide range of clinical scenarios, from acute care to minimally invasive and robotic surgery.
The U.S. patent represents not only legal protection but also validation of our mission: to make suturing simpler, safer, and more efficient, thereby enabling healthcare professionals to dedicate more time to what matters most – their patients.
With this milestone, MUB Medical is even better positioned to scale globally, enter new markets, and continue driving innovation in acute wound closure.
Together, we are shaping the future of acute wound closure.
Yasar Shaikh
Yasar Shaikh is the CEO and co-founder of MUB Medical Solutions. With a strong background in innovation and strategic development, Yasar is dedicated to transforming acute wound closure through technology that is simple, safe, and scalable. Drawing on Scandinavian design principles and real-world clinical needs, he leads the development of Sutrips®️ – a patented wound closure technology designed to simplify procedures, empower medical teams, and improve patient outcomes. Yasar is driven by a passion for bridging the gap between concept and execution, ensuring that every step – from product design to regulatory strategy – serves the people who matter most: healthcare professionals and their patients.
Recent Comments